CELGENE GLOBAL HEALTH
DEAD

Serial Number

85101797

Owner

Celgene Corporation

Attorney

Camille M. Miller

First Use Date

Apr 14, 2010

Filing Date

Aug 6, 2010

Add to watchlist:

No watchlists yet
View on USPTO

CELGENE GLOBAL HEALTH Trademark

Serial Number: 85101797 • Registration: 3931147

CELGENE GLOBAL HEALTH is a trademark filed by Celgene Corporation on August 6, 2010. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Celgene Corporation (883 trademarks)

7 Powder Horn Drive
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

August 6, 2010

Registration Date

March 15, 2011

First Use Anywhere

April 14, 2010

First Use in Commerce

April 14, 2010

Published for Opposition

December 28, 2010

Cancellation Date

October 26, 2021

Goods & Services

[ Education services, namely, providing mentoring, tutoring, classes, seminars, and workshops in the fields of highlighting the advancements made in cancer treatments and discussing the importance of continuing research to develop innovative new treatments ]

[ Charitable fund raising services, namely, by providing individuals with the information and opportunity to make monetary donations to their favorite charity; charitable foundation services, namely, providing fund raising activities to support medical research and procedures for those in need; charitable fund raising services for sending underprivileged children to one of several camps around the United States which accept these children at discounted rates for one or more weeks; charitable fund raising services by means of an entertainment event; charitable fund raising services, namely, eleemosynary services in the field of collection, management, and disbursements of money in connection with programs and facilities for the welfare of children; financial services, namely, business fund raising provided over a computer network such as the Internet; charitable services, namely, providing financial assistance to patients and their families, charitable services, namely, providing funding to health care facilities and foundations for patients, charitable fund raising services; providing project grants for environmental and health awareness projects; charitable services, namely, providing financial support to disadvantaged patients for the purpose of facilitating good health ]

[ Providing links to web sites of others featuring information about the diagnosis and treatment of cancer; providing on-line information in the field of diagnosis and treatment of cancer; providing an on-line computer database featuring information relating to diagnosis and treatment of cancer; providing medical and pharmaceutical information services ]

Development and testing services in the fields of biotechnology, chemistry and pharmaceuticals; [ providing an interactive web site that enables users to enter, access, track, monitor and generate health and medical information and reports; ] scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services, namely, pharmacogenetic tests, predictive medical tests, personalized medical tests, gene sequencing-based tests and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research services; scientific research, namely, development of pharmaceuticals or diagnostic methods for others

Filing History

NOTICE OF CANCELLATION SEC. 8 EMAILED
Oct 27, 2021 NCS8
CANCELLED SEC. 8 (10-YR)
Oct 26, 2021 C8.T
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 16, 2021 APRE
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
May 15, 2020 PR89
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 11, 2020 APRE
TEAS SECTION 8 & 9 RECEIVED
Mar 16, 2020 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Mar 15, 2020 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 25, 2016 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 25, 2016 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 24, 2016 APRE
TEAS SECTION 8 & 15 RECEIVED
Mar 15, 2016 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 15, 2016 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 28, 2015 TCCA
REGISTERED-PRINCIPAL REGISTER
Mar 15, 2011 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 28, 2010 NPUB
PUBLISHED FOR OPPOSITION
Dec 28, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 24, 2010 PREV
ASSIGNED TO LIE
Nov 18, 2010 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 2, 2010 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 6, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 5, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 5, 2010 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 4, 2010 GNRN
NON-FINAL ACTION E-MAILED
Oct 4, 2010 GNRT
NON-FINAL ACTION WRITTEN
Oct 4, 2010 CNRT
ASSIGNED TO EXAMINER
Sep 27, 2010 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Aug 12, 2010 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2010 NWOS
NEW APPLICATION ENTERED
Aug 10, 2010 NWAP